Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Thitinan Aiebchun"'
Autor:
Phuntila Tharabenjasin, Aekkacha Moonwiriyakit, Jenjira Sontikun, Kanokphorn Timpratueang, Suhaibee Kuno, Thitinan Aiebchun, Nathjanan Jongkon, Rungrawee Mongkolrob, Noel Pabalan, Kiattawee Choowongkomon, Chatchai Muanprasat
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0302851 (2024)
Allergic inflammation, which is the pathogenesis of allergic rhinitis and asthma, is associated with disruption of the airway epithelial barrier due to the effects of type 2 inflammatory cytokines, i.e. interleukin-4 and interleukin-13 (IL-4/13). The
Externí odkaz:
https://doaj.org/article/5dada3964cc44721bcb753c2d9f8ac21
Autor:
Suchada Kaewin, Wanangkan Poolsri, Gül Gizem Korkut, Jaakko Patrakka, Thitinan Aiebchun, Thanyada Rungrotmongkol, Titiwat Sungkaworn, I.Butu Sukanadi, Warinthorn Chavasiri, Chatchai Muanprasat
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 165, Iss , Pp 115158- (2023)
Diabetic nephropathy (DN) is a serious complication of diabetes mellitus (DM), which currently lacks effective treatments. AMP-activated protein kinase (AMPK) stimulation by chalcones, a class of polyphenols abundantly found in plants, is proposed as
Externí odkaz:
https://doaj.org/article/2705d379f0a54dbdb211b9aa70714b66
Autor:
Lueacha Tabtimmai, Prapasri Supakun, Borvornvat Toviwek, Nattanan Jiwacharoenchai, Duangnapa Kiriwan, Thitinan Aiebchun, M. Paul Gleeson, Kiattawee Choowongkomon
Publikováno v:
European Journal of Medicinal Chemistry Reports, Vol 5, Iss , Pp 100062- (2022)
Target therapies have been widely developed to combat various diseases and cancer. Epidermal Growth Factor Receptor is still a currently therapeutic target for solid tumor. Aberration of EGFR activity or expression reflect disease progression and poo
Externí odkaz:
https://doaj.org/article/6f904371d7ac4ce696c3d1b593f364ab
Autor:
Duangjai Todsaporn, Alexander Zubenko, Victor Kartsev, Thitinan Aiebchun, Panupong Mahalapbutr, Anthi Petrou, Athina Geronikaki, Liudmila Divaeva, Victoria Chekrisheva, Ilkay Yildiz, Kiattawee Choowongkomon, Thanyada Rungrotmongkol
Publikováno v:
Molecules, Vol 28, Iss 7, p 3014 (2023)
Targeting L858R/T790M and L858R/T790M/C797S mutant EGFR is a critical challenge in developing EGFR tyrosine kinase inhibitors to overcome drug resistance in non-small cell lung cancer (NSCLC). The discovery of next-generation EGFR tyrosine kinase inh
Externí odkaz:
https://doaj.org/article/551a531ba4fd47eebd77d51c671c2851
Autor:
Kanika Verma, Panupong Mahalapbutr, Utid Suriya, Tuanjai Somboon, Thitinan Aiebchun, Liyi Shi, Phornphimon Maitarad, Thanyada Rungrotmongkol
Publikováno v:
Brazilian Archives of Biology and Technology, Vol 64 (2021)
Abstract Clostridium difficile infection (CDI) is the most common hospital acquired diarrheal disease with its increasing incidence and mortality rate globally. DNA Gyrase B (GyrB) is a key component of DNA replication process across all bacterial ge
Externí odkaz:
https://doaj.org/article/08a826cbe41245899c92207c7a1bfa34
Autor:
Thitinan Aiebchun, Panupong Mahalapbutr, Atima Auepattanapong, Onnicha Khaikate, Supaphorn Seetaha, Lueacha Tabtimmai, Chutima Kuhakarn, Kiattawee Choowongkomon, Thanyada Rungrotmongkol
Publikováno v:
Molecules, Vol 26, Iss 8, p 2211 (2021)
Epidermal growth factor receptor (EGFR), overexpressed in many types of cancer, has been proved as a high potential target for targeted cancer therapy due to its role in regulating proliferation and survival of cancer cells. In the present study, a s
Externí odkaz:
https://doaj.org/article/0755dedd19234c8d988d7cd22d8db2a8
Autor:
Thitinan Aiebchun, Natchaya Rasri, Duangnapa Kiriwan, Suradej Siripattanapipong, Kiattawee Choowongkomon
Publikováno v:
Acta Parasitologica. 68:240-248
Autor:
Jeeraprapa Siriwaseree, Kamonpan Sanachai, Thitinan Aiebchun, Lueacha Tabtimmai, Buabarn Kuaprasert, Kiattawee Choowongkomon
Publikováno v:
ACS Omega. 7:22797-22803
Janus kinase (JAK) deregulation of the JAK/signal transducers and activators of transcription pathway leads to myelofibrosis that can be treated by JAK inhibitors including Ruxolitinib and Tofacitinib. Even though both inhibitors are effective agains
Autor:
Kowit Hengphasatporn, Thitinan Aiebchun, Panupong Mahalapbutr, Atima Auepattanapong, Onnicha Khaikate, Kiattawee Choowongkomon, Chutima Kuhakarn, Jatuporn Meesin, Yasuteru Shigeta, Thanyada Rungrotmongkol
Publikováno v:
ACS Omega.
Autor:
Supaphorn Seetaha, Phatcharin Khamplong, Panatda Wanaragthai, Thitinan Aiebchun, Siriluk Ratanabunyong, Sucheewin Krobthong, Yodying Yingchutrakul, Jatuporn Rattanasrisomporn, Kiattawee Choowongkomon
Publikováno v:
COVID; Volume 2; Issue 5; Pages: 621-632
The COVID-19 pandemic affects all parameters, especially healthcare professionals, drugs and medical supplies. The KERRA is a mixed medicinal plant capsule that is used for the treatment of patients with high fever, with food and drug administration